CGP-53153 is a steroidal inhibitor of 5 alpha-reductase (IC50s: 36 and 262 nM in rat and human prostatic tissue).

CGP-53153 competitively inhibits rat microsomal 5 alpha-reductase from the prostate (IC50: 36 nM) compared to the reference compound finasteride (IC50: 11 nM).

CGP-53153 (0.01 mg/kg, p.o.) can significantly reduce T-propionate-mediated prostate growth. CGP-53153 significantly reduces prostate weight at 3 and 10 mg/kg by 31% and 37%, respectively. Treatment for 12 weeks with both CGP-53153 reduces prostate volume by more than 70% in individual dogs. Neither body weight nor the weight of any organ tested is affected by CGP-53153.

149281-19-6

C23H33N3O2

383.53

CGP-53153

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years